The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018-2021.

Nashira Popovic, Qiuying Yang, Laurence Campeau, Janelle Elliott, Anson Williams, Viviane D Lima, Paul Sereda, Joseph Cox
{"title":"The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018-2021.","authors":"Nashira Popovic, Qiuying Yang, Laurence Campeau, Janelle Elliott, Anson Williams, Viviane D Lima, Paul Sereda, Joseph Cox","doi":"10.14745/ccdr.v51i01a05","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Measuring trends in HIV pre-exposure prophylaxis (HIV-PrEP) uptake is important to inform planning for prevention programs and policies. The HIV-PrEP-to-need ratio (PnR) is a construct used by public health organizations to explore disparities in the provision of HIV-PrEP across geographic areas and demographic categories (e.g., age, sex).</p><p><strong>Methods: </strong>This is a retrospective database review study using administrative pharmacy data, containing limited demographic information, from nine Canadian provinces. Annual estimates of persons taking HIV-PrEP and PnR were generated using data from the company IQVIA and the BC Centre for Excellence on HIV/AIDS. Data on new HIV diagnoses were obtained from the National HIV Surveillance System. The PnR was defined as the number of HIV-PrEP users divided by the number of new HIV diagnoses annually and is interpreted as the number of HIV-negative people using HIV-PrEP each year for every person newly diagnosed with HIV.</p><p><strong>Results: </strong>In 2021, an estimated 23,644 individuals were prescribed HIV-PrEP, corresponding to an HIV-PrEP prevalence of 66.9 per 100,000 persons. This represents a 1.8-fold increase since 2018. The overall PnR was 16.8, meaning that for every person newly diagnosed with HIV, 17 HIV-negative individuals were taking HIV-PrEP. There were disparities between provinces (PnR range: 1.5/100,000-37.7/100,000) and between males and females (PnR 22.6 and 1.2, respectively). Females, individuals aged 0-19 years, and those in Manitoba, Saskatchewan and Prince Edward Island, had lower levels of HIV-PrEP use relative to epidemic need.</p><p><strong>Conclusion: </strong>In Canada, the use of HIV-PrEP increased from 2018 to 2021 and uptake varied by age, sex and province. HIV-PrEP-to-need ratio is a useful measure to assess uptake of HIV-PrEP as a prevention strategy and could be used to explore disparities in provision across provinces and available demographic categories. However, PnR could be improved with more information on key populations and other attributes, such as race/ethnicity, socioeconomic status and residence of city/rural area.</p>","PeriodicalId":94304,"journal":{"name":"Canada communicable disease report = Releve des maladies transmissibles au Canada","volume":"51 1","pages":"35-42"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11709143/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canada communicable disease report = Releve des maladies transmissibles au Canada","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14745/ccdr.v51i01a05","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Measuring trends in HIV pre-exposure prophylaxis (HIV-PrEP) uptake is important to inform planning for prevention programs and policies. The HIV-PrEP-to-need ratio (PnR) is a construct used by public health organizations to explore disparities in the provision of HIV-PrEP across geographic areas and demographic categories (e.g., age, sex).

Methods: This is a retrospective database review study using administrative pharmacy data, containing limited demographic information, from nine Canadian provinces. Annual estimates of persons taking HIV-PrEP and PnR were generated using data from the company IQVIA and the BC Centre for Excellence on HIV/AIDS. Data on new HIV diagnoses were obtained from the National HIV Surveillance System. The PnR was defined as the number of HIV-PrEP users divided by the number of new HIV diagnoses annually and is interpreted as the number of HIV-negative people using HIV-PrEP each year for every person newly diagnosed with HIV.

Results: In 2021, an estimated 23,644 individuals were prescribed HIV-PrEP, corresponding to an HIV-PrEP prevalence of 66.9 per 100,000 persons. This represents a 1.8-fold increase since 2018. The overall PnR was 16.8, meaning that for every person newly diagnosed with HIV, 17 HIV-negative individuals were taking HIV-PrEP. There were disparities between provinces (PnR range: 1.5/100,000-37.7/100,000) and between males and females (PnR 22.6 and 1.2, respectively). Females, individuals aged 0-19 years, and those in Manitoba, Saskatchewan and Prince Edward Island, had lower levels of HIV-PrEP use relative to epidemic need.

Conclusion: In Canada, the use of HIV-PrEP increased from 2018 to 2021 and uptake varied by age, sex and province. HIV-PrEP-to-need ratio is a useful measure to assess uptake of HIV-PrEP as a prevention strategy and could be used to explore disparities in provision across provinces and available demographic categories. However, PnR could be improved with more information on key populations and other attributes, such as race/ethnicity, socioeconomic status and residence of city/rural area.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2018-2021年加拿大9省艾滋病毒暴露前预防(HIV- prep)使用率和HIV- prep需求比
背景:测量艾滋病毒暴露前预防(HIV- prep)使用趋势对制定预防方案和政策具有重要意义。艾滋病毒预防与需求比率(PnR)是公共卫生组织用来探索不同地理区域和人口类别(如年龄、性别)提供艾滋病毒预防方面的差异的一种结构。方法:这是一项回顾性数据库回顾研究,使用来自加拿大九个省的行政药房数据,包含有限的人口统计信息。利用IQVIA公司和不列颠哥伦比亚省艾滋病毒/艾滋病卓越中心的数据,对服用艾滋病毒prep和PnR的人进行了年度估计。新的艾滋病毒诊断数据来自国家艾滋病毒监测系统。PnR被定义为HIV- prep使用者的数量除以每年新诊断的HIV病毒的数量,并被解释为每年使用HIV- prep的HIV阴性患者的数量与每一个新诊断的HIV病毒感染者的数量。结果:2021年,估计有23,644人接受了HIV-PrEP处方,相当于每10万人中有66.9人感染HIV-PrEP。这是自2018年以来的1.8倍。总体PnR为16.8,这意味着每有一个新诊断为艾滋病毒的人,就有17个艾滋病毒阴性的人正在接受艾滋病毒预防。省际间(PnR为1.5/10万~ 37.7/10万)和男女间(PnR分别为22.6和1.2)存在差异。年龄在0-19岁之间的女性,以及马尼托巴省、萨斯喀彻温省和爱德华王子岛的女性,与流行病的需要相比,使用HIV-PrEP的水平较低。结论:在加拿大,从2018年到2021年,HIV-PrEP的使用有所增加,且使用情况因年龄、性别和省份而异。HIV-PrEP与需求的比率是评估将HIV-PrEP作为一项预防战略的采用情况的有用措施,可用于探索各省和现有人口类别之间提供的差异。然而,PnR可以通过更多关于关键人口和其他属性的信息来改进,例如种族/民族、社会经济地位和城市/农村地区的居住地。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Burden of disease of respiratory syncytial virus in older adults and adults considered at high risk of severe infection. Is there sufficient evidence to inform personal protective equipment choices for healthcare workers caring for patients with viral hemorrhagic fevers? Summary of the National Advisory Committee on Immunization (NACI) Statement-Updated guidance on Imvamune in the context of a routine immunization program. Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2023. The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018-2021.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1